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The not-so-minimal lesions of the 
idiopathic nephrotic syndrome of 
childhood
PE Birk1
Dijkman et al. describe a unique form of glomerular involution in 
children with idiopathic nephrotic syndrome (INS). These lesions are 
small and sclerotic but retain their podocyte and parietal epithelial cell 
constituents. Multicenter studies are needed to address the clinical 
implications of the changing histological pattern of INS in children.
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within the renal cortex is more sinister 
than what was previously described.
Into this histological conundrum 
falls the study of Dijkman et al.,6 who, 
in a recent issue of Kidney Interna-
tional, reported the presence of a unique 
glomerulosclerotic lesion in two-thirds of 
a group of children with steroid-depend-
ent or frequently relapsing INS (Figure 
1). Using immunohistochemical markers 
for glomerular cell constituents and extra-
cellular matrix proteins, the authors ele-
gantly characterized this lesion as a form 
of glomerular involution, distinguishing 
it from the classic glomerulopathic and 
vascular types of glomerulosclerosis.
Th e presence of this glomerular lesion in 
children with INS raises several questions. 
First, is it new? Th e original ISKDC data 
suggested that the highly predictive value 
of steroid responsiveness for renal histol-
ogy obviated the need for renal biopsy in 
patients with uncomplicated INS, result-
ing in the discontinuation of this prac-
tice.1,4,7 Therefore, both the incidence 
and the natural history of glomerular 
involution in these children are unknown. 
Small sclerotic glomeruli have been previ-
ously reported in children with congenital 
nephrotic syndrome,8 but because they 
were not characterized with immunohis-
tochemical markers, their precise pheno-
type and pathogenesis remain unknown. 
Interestingly, in the study of Dijkman et 
al.,6 the presence of microglomeruli was 
not predictive of outcome.
Th ere is now suffi  cient evidence to con-
clude that in children, the histological 
pattern of idiopathic nephrotic syndrome 
(INS) is changing. In the 1978 report of 
the International Study of Kidney Dis-
ease in Children (ISKDC), the most com-
mon biopsy fi nding in INS was minimal 
change histology, which was seen in 77% 
of patients.1 In contrast, focal segmen-
tal glomerulosclerosis (FSGS) was only 
rarely observed (8% of children).1 Over 
the past decade, however, several inves-
tigators have noted a substantial increase 
in the incidence of FSGS in children with 
INS.2–5 In one such study, the incidence 
of FSGS in children presenting with new-
onset INS before 1990 more than doubled 
aft er 1990 (23% versus 47%).2 At another 
center with an ethnic composition simi-
lar to that of the ISKDC patients, the inci-
dence of FSGS had increased dramatically 
from 0.37 per 100,000 children per year 
(1985–1993) to 0.94 per 100,000 children 
per year (1993–2002).4
In the original ISKDC paper, 93% of 
children responded to steroid therapy.1 
However, in a recent investigation, initial 
steroid responsiveness was observed in 
only 71% of children with INS, or 61% 
of the overall cohort.5 In the same study, 
depending on the classifi cation of steroid 
responsiveness, FSGS was seen in 21%–
75% of patients, and minimal change 
histology was found in only 17%–47% 
of these children. Th is disturbing trend 
has been documented worldwide and is 
particularly evident in African-American 
children.2–4 In fact, at one center, FSGS 
has become the leading cause of child-
hood INS in this ethnic group (69%).2 
Th e etiologies of this changing histological 
pattern are presently unknown, but there 
is speculation that the parallel increase in 
childhood obesity may be a causal factor.4 
(Th is hypothesis remains to be validated 
in population studies.) One could argue 
that in today’s child with INS, what lies 
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E-mail: pbirk@hsc.mb.ca Figure 1 | Glomerular involution in children with idiopathic nephrotic syndrome.
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Vasopressin: A look at dialysis 
hypertension and autonomic 
dysfunction
MJ Flanigan1,2
Dialysis hypertension is a complex disorder in which ambient vascular 
resistance is too high for the blood volume. van der Zee et al. remind us 
that this is contingent upon the endothelium itself, and that endothelial 
dysfunction is integral to uremia. Thus, while vasopressin may not abolish 
dialysis hypotension, its effects highlight the influence of uremia on the 
autocrine and neuroendocrine control of cardiovascular physiology.
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In view of the increasing incidence of 
FSGS, it is appropriate to ask whether 
this lesion is part of the minimal change–
FSGS continuum. Th e absence of epithe-
lial-cell proliferation, activated parietal 
cells, podocyte dedifferentiation, and 
periglomerular and tubulointerstitial 
fi brosis suggests a diff erent pathological 
process than what has been described for 
FSGS.9–11 Nevertheless, it is intriguing 
that the glomerular changes were detected 
in refractory INS patients and not in non-
proteinuric controls. Additional studies 
are therefore required to describe the 
pathogenesis of this lesion. And fi nally, 
despite the lack of predictive value of 
microglomeruli in congenital nephrotic 
syndrome, it is important to determine 
whether these lesions are harbingers of 
chronic kidney disease.12 Longitudinal 
evaluation of this cohort may provide 
insights into histological progression.
Several years ago, in a Kidney Interna-
tional editorial addressing the increas-
ing incidence of FSGS in children, one 
author presciently remarked, “Th e more 
one reads and asks, the more apparent our 
lack of understanding becomes; we know 
very little about INS in childhood.”12 Sub-
sequent studies have consistently demon-
strated a more severe form of histology 
underlying childhood INS. Th e clinical 
significance of the glomerular lesions 
described by Dijkman et al.6 and by other 
researchers in these patients would be best 
addressed by a prospective multicenter 
study sufficiently powered to evaluate 
contemporary risk factors and clinically 
appropriate end points — in other words, 
an ISKDC for the new millennium.
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Hemodialysis is an empiric therapy 
encumbered by two dominating complica-
tions: hypertension and ‘dialysis discom-
fort’. Between 60% and 90% of patients 
initiating dialysis are hypertensive,1 and 
vascular disease inclusive of sudden death, 
myocardial infarction, stroke, and conges-
tive heart failure accounts for approxi-
mately 50% of dialysis patient mortality.2 
Since the inception of maintenance dial-
ysis, blood pressure control has been an 
essential goal of therapy. Dialysis pioneers 
assumed that kidney disease was a form 
of ‘salt-sensitive hypertension’ that would 
respond to normalization of total body 
sodium. Thus, early dialysis prescrip-
tions combined vigorous dietary sodium 
restriction with hyponatremic dialysate 
to achieve this goal. Th is controlled blood 
pressure but provoked dialysis disequilib-
rium and discomfort. As dialyzers became 
more durable, ultrafi ltration became the 
primary means of regulating extracellu-
lar volume and total body sodium. Physi-
cians attempted to achieve normal blood 
pressure by achieving the lowest postdi-
alysis weight possible without incurring 
symptomatic hypotension, referring to 
this weight as the ‘dry’ or ‘target’ weight. 
In the past two decades, high-effi  ciency 
dialysis combined with transmembrane 
ultrafiltration has become the rule in 
maintenance hemodialysis, but as a con-
sequence the most common therapeutic 
complications are interdialytic hyperten-
sion and intradialytic hypotension.
